139 related articles for article (PubMed ID: 19289282)
1. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
Liu J; Shiono J; Shimizu K; Kukita A; Kukita T; Kondo R
Bioorg Med Chem Lett; 2009 Apr; 19(8):2154-7. PubMed ID: 19289282
[TBL] [Abstract][Full Text] [Related]
2. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum.
Liu J; Shimizu K; Konishi F; Kumamoto S; Kondo R
Bioorg Med Chem; 2007 Jul; 15(14):4966-72. PubMed ID: 17499997
[TBL] [Abstract][Full Text] [Related]
3. Anti-androgen effects of extracts and compounds from Ganoderma lucidum.
Liu J; Tamura S; Kurashiki K; Shimizu K; Noda K; Konishi F; Kumamoto S; Kondo R
Chem Biodivers; 2009 Feb; 6(2):231-43. PubMed ID: 19235153
[TBL] [Abstract][Full Text] [Related]
4. Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum.
Miyamoto I; Liu J; Shimizu K; Sato M; Kukita A; Kukita T; Kondo R
Eur J Pharmacol; 2009 Jan; 602(1):1-7. PubMed ID: 19026632
[TBL] [Abstract][Full Text] [Related]
5. Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria.
Liu J; Shiono J; Shimizu K; Kondo R
Planta Med; 2010 Feb; 76(2):137-9. PubMed ID: 19670160
[TBL] [Abstract][Full Text] [Related]
6. Anti-androgenic activities of Ganoderma lucidum.
Fujita R; Liu J; Shimizu K; Konishi F; Noda K; Kumamoto S; Ueda C; Tajiri H; Kaneko S; Suimi Y; Kondo R
J Ethnopharmacol; 2005 Oct; 102(1):107-12. PubMed ID: 16029938
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum.
Liu J; Kurashiki K; Shimizu K; Kondo R
Bioorg Med Chem; 2006 Dec; 14(24):8654-60. PubMed ID: 16962782
[TBL] [Abstract][Full Text] [Related]
8. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells.
Yue QX; Song XY; Ma C; Feng LX; Guan SH; Wu WY; Yang M; Jiang BH; Liu X; Cui YJ; Guo DA
Phytomedicine; 2010 Jul; 17(8-9):606-13. PubMed ID: 20092987
[TBL] [Abstract][Full Text] [Related]
9. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum.
Luo J; Zhao YY; Li ZB
J Asian Nat Prod Res; 2002 Jun; 4(2):129-34. PubMed ID: 12067158
[TBL] [Abstract][Full Text] [Related]
10. Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402.
Yang HL
Biotechnol Lett; 2005 Jun; 27(12):835-8. PubMed ID: 16086244
[TBL] [Abstract][Full Text] [Related]
11. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
[TBL] [Abstract][Full Text] [Related]
12. Anti-androgenic activity of fatty acids.
Liu J; Shimizu K; Kondo R
Chem Biodivers; 2009 Apr; 6(4):503-12. PubMed ID: 19353546
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic triterpenoids from Ganoderma lucidum.
Cheng CR; Yue QX; Wu ZY; Song XY; Tao SJ; Wu XH; Xu PP; Liu X; Guan SH; Guo DA
Phytochemistry; 2010 Sep; 71(13):1579-85. PubMed ID: 20615519
[TBL] [Abstract][Full Text] [Related]
14. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells.
Min BS; Gao JJ; Nakamura N; Hattori M
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):1026-33. PubMed ID: 10923835
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum.
Akihisa T; Nakamura Y; Tagata M; Tokuda H; Yasukawa K; Uchiyama E; Suzuki T; Kimura Y
Chem Biodivers; 2007 Feb; 4(2):224-31. PubMed ID: 17311233
[TBL] [Abstract][Full Text] [Related]
16. The effects of ganoderma alcohols isolated from Ganoderma lucidum on the androgen receptor binding and the growth of LNCaP cells.
Liu J; Shimizu K; Kondo R
Fitoterapia; 2010 Dec; 81(8):1067-72. PubMed ID: 20603196
[TBL] [Abstract][Full Text] [Related]
17. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
18. Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
Liang C; Tian D; Liu Y; Li H; Zhu J; Li M; Xin M; Xia J
Eur J Med Chem; 2019 Jul; 174():130-141. PubMed ID: 31035236
[TBL] [Abstract][Full Text] [Related]
19. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth.
Ruan W; Lim AH; Huang LG; Popovich DG
Nat Prod Res; 2014; 28(24):2264-72. PubMed ID: 25032738
[TBL] [Abstract][Full Text] [Related]
20. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity.
Seo HW; Hung TM; Na M; Jung HJ; Kim JC; Choi JS; Kim JH; Lee HK; Lee I; Bae K; Hattori M; Min BS
Arch Pharm Res; 2009 Nov; 32(11):1573-9. PubMed ID: 20091270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
